AI assistant
Sending…
Cue Biopharma, Inc. — Director's Dealing 2021
Feb 1, 2021
34525_dirs_2021-02-01_ea692982-08b5-4555-8c9b-ac17054817f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2020-12-31
Reporting Person: Gray Cameron (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-02 | Common Stock | G | 596200 | $0.00 | Disposed | 81300 | Direct |
| 2020-12-02 | Common Stock | G | 162600 | $0.00 | Acquired | 162600 | Indirect |
| 2020-12-02 | Common Stock | G | 162600 | $0.00 | Acquired | 162600 | Indirect |
| 2020-12-02 | Common Stock | G | 271000 | $0.00 | Acquired | 271000 | Indirect |
More from Cue Biopharma, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Regulatory Filings
2026
Jun 3
Regulatory Filings
2026
Jun 3
Board/Management Information
2026
Jun 2
Proxy Solicitation & Information Statement
2026
May 21
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 13
Regulatory Filings
2026
Apr 7